ArticleJournal of industrial microbiology & biotechnology2026
Kratom medium-chain dehydrogenase/reductase enzymes exhibit broad substrate and cofactor promiscuity.
Article in Journal of industrial microbiology & biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Medium-chain alcohol dehydrogenases/reductases (MDRs) are crucial to the biosynthesis of plant monoterpene indole alkaloids (MIAs), yet studies have focused solely on their catalytic activities with strictosidine aglycone derivatives and NADPH as the redox cofactor. Here, we combined computational and experimental approaches to characterize the substrate and cofactor promiscuity of five MDRs recently identified in the medicinal plant kratom, including MsMDR4, MsMDR11, MsTHAS (tetrahydroalstonine synthase), MsDCS1 (dihydrocorynantheine synthase), and MsHYS (heteroyohimbine synthase). In vitro and yeast-based biochemical analyses showed that MsMDR4, MsMDR11, and MsTHAS catalyze the aldehyde reduction for cinnamaldehyde and 8-oxogeraniol, while MsMDR11 and MsTHAS also catalyze the alcohol oxidation for cinnamyl alcohol and 8-hydroxygeraniol. In particular, MsMDR11 exhibits 8-hydroxygeraniol oxidoreductase activity, producing 8-oxogeranial, an upstream intermediate in the strictosidine pathway. Additionally, all five enzymes can accept NADH/NAD + as redox cofactors, though with decreased productivity. Swapping the reducing cofactor from NADPH to NADH further alters the distribution of MIAs produced by MsDCS1 and MsHYS. Together, kratom MDRs exhibit great plasticity and potential for future enzyme engineering. One-sentence summary Computational and biochemical analyses revealed that previously identified kratom medium-chain dehydrogenase/reductases exhibit broad substrate and cofactor promiscuity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.